Company Overview of Vivo Capital, LLC
Vivo Capital, LLC is a private equity and venture capital firm specializing in incubation, seed, startup, mezzanine, and PIPE investments in private and public companies. The firm seeks to invest in all financing stages from Series A to public companies. It primarily invests in healthcare, biotechnology, and life science companies. The firm also seeks to invest in companies with later-stage therapeutic products in clinical development. It typically makes investments in United States and Asia Pacific based companies with a focus on later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo Capital, LLC was f...
575 High Street
Palo Alto, CA 94301
Founded in 1996
Key Executives for Vivo Capital, LLC
Managing Director and Chief Investment Officer
Managing Partner and Founding Member
Compensation as of Fiscal Year 2016.
Vivo Capital, LLC Key Developments
Vivo Capital Closes Vivo Panda Fund At over $100 Million; Announces Opening of its Office in Taipei, Taiwan
Jun 13 16
Vivo Capital announced the closing of a new healthcare venture capital focused fund, the Vivo PANDA Fund, at over $100 million. Vivo plans to invest the capital primarily in innovative early-stage healthcare companies across the industry spectrum, including pharmaceuticals, biotechnology, medical devices, and diagnostics. The addition of Vivo PANDA will enable the firm to invest in all stages in the life science industry's development cycles. Vivo PANDA will complement and build synergies with Vivo Capital Fund VIII, which invests primarily in later development stage and growth stage healthcare companies.
In addition to the close of the fund, the firm also announced the opening of its office in Taipei, Taiwan. The firm's new Taipei office is located at 18/F, No. 460, Section 4, Xinyi Road, Xinyi District, Taipei, Taiwan.
Vivo Seeks to Expand
Jun 13 16
Vivo Capital, LLC closed the new healthcare venture capital fund at over $100 million. Vivo PANDA Fund will be used to invest primarily in early-stage healthcare companies across the industry spectrum, including pharmaceuticals, biotech, medical devices and diagnostics. Vivo said it also wants to continue its strategy of “collaborating with portfolio companies on both sides of the Pacific in their efforts to forge cross-border partnerships” with the money.
Vivo Capital, LLC Presents at 6th Annual China Healthcare Investment Conference, Mar-29-2016 through Apr-02-2016
Jan 5 16
Vivo Capital, LLC Presents at 6th Annual China Healthcare Investment Conference, Mar-29-2016 through Apr-02-2016. Venue: 33 Fu Cheng Road, Pudong, Shanghai 200120, China. Presentation Date & Speakers: Apr-01-2016, Chen-Ming Yu, Managing Partner, Frank F. C. Kung, Senior Managing Partner.
Similar Private Companies By Industry
Recent Private Companies Transactions